Patent: 6,881,423
✉ Email this page to a colleague
Summary for Patent: 6,881,423
Title: | Powdery composition for nasal administration |
Abstract: | A powdery composition for nasal administration, where (1) the composition contains (i) a drug, (ii) a water-absorbing and gel-forming base material such as hydroxyprophyl cellulose or hydroxpropylmethyl cellulose and (iii) a water-absorbing and water-insoluble base material such as crystalline cellulose or .alpha.-cellulose, (2) wherein the amount of water-absorbing and gel-forming base material is about 5-40 wt. % based on the total of the water-absorbing and gel-forming base material and the water-absorbing and water-insoluble base material, and (3) wherein the drug is unevenly dispersed more on/in the water-absorbing and water-insoluble base material than on/in the water-absorbing and gel-forming base material. |
Inventor(s): | Dohi; Masahiko (Hino, JP), Nishibe; Yoshihisa (Hino, JP), Makino; Yuji (Tokyo, JP), Fujii; Tako (Hino, JP) |
Assignee: | Teijin Limited (Osaka, JP) |
Application Number: | 09/125,814 |
Patent Claims: | see list of patent claims |
Details for Patent 6,881,423
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2016-02-27 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |